Clinical Trial Update: Study to Evaluate Safety and Efficacy of IBsolvMIR in Islet Transplantation [Phase 2]

View source ↗

Summary

Phase 2 study evaluating the safety and efficacy of IBsolvMIR in islet transplantation for type 1 diabetes has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 1 Diabetes Mellitus

Drugs mentioned

• IBsolvMIR

Snippet

Sponsor: TikoMed AB | Conditions: Diabetes Mellitus, Type 1 | Phase 2 | Status: TERMINATED